Lv31
308 积分 2025-12-03 加入
Current outlook on the use of monoclonal antibody therapies for osteoporosis
3小时前
已关闭
Current outlook on the use of monoclonal antibody therapies for osteoporosis
3小时前
已关闭
Revolutionizing osteoporosis management: the emerging role of immunotherapeutic and next-generation therapies
14天前
已完结
Monoclonal antibodies for treating osteoporosis
14天前
已完结
Monoclonal antibodies for treatment of osteoporosis
14天前
已完结
Recent Advances in Osteoporosis Therapeutics
14天前
已完结
Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis
20天前
已完结
Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
20天前
已完结
Comparative efficacy between monoclonal antibodies and conventional drugs in postmenopausal women with osteoporosis: a network meta-analysis
23天前
已完结
Single - and multiple dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women
23天前
已完结
皖公网安备34019202002308
